Skip to main content

NextCure, Inc.

NXTC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001661059

In the last 90 days, NextCure, Inc. insiders filed 2 open-market purchases and 1 sale; 30 institutions reported holding it in 13F filings for Q2 2026, worth $2.78M in total; no superinvestor holds it.

Members of Congress who traded NXTC

No member of Congress has reported a trade in NextCure, Inc. since 2020.

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.